Life Sciences

Peripheral Liquid Embolic Agents Market was valued at US$ 40.42 Million in 2023 and is expected to reach US$ 81.41 Million by 2031; it is estimated to record a CAGR of 9.1% from 2023 to 2031

• Biotechnology
• Life Sciences

Peripheral Liquid Embolic Agents Market was valued at US$ 40.42 Million in 2023 and is expected to reach US$ 81.41 Million by 2031; it is estimated to record a CAGR of 9.1% from 2023 to 2031

Market News Insights December 9, 2024

Developments in Temperature-Induced Phase Change Systems and pH-Triggered Embolic Agents Drive Market Growth Temperature-sensitive polymer solutions can...

Read More Read more about Peripheral Liquid Embolic Agents Market was valued at US$ 40.42 Million in 2023 and is expected to reach US$ 81.41 Million by 2031; it is estimated to record a CAGR of 9.1% from 2023 to 2031

Crohn’s Disease Therapeutics Market was valued at US$ 9.68 Billion in 2023 and is expected to reach US$ 13.33 Billion by 2031; it is estimated to record a CAGR of 4.1% from 2023 to 2031

• Life Sciences
• Pharmaceuticals

Crohn’s Disease Therapeutics Market was valued at US$ 9.68 Billion in 2023 and is expected to reach US$ 13.33 Billion by 2031; it is estimated to record a CAGR of 4.1% from 2023 to 2031

Market News Insights December 6, 2024

Growing Number of Drug Developments and Regulatory Approvals Drives Crohn’s Disease Therapeutics Market Growth The majority of...

Read More Read more about Crohn’s Disease Therapeutics Market was valued at US$ 9.68 Billion in 2023 and is expected to reach US$ 13.33 Billion by 2031; it is estimated to record a CAGR of 4.1% from 2023 to 2031

Proton Therapy Systems Market was valued at US$ 1,262.45 Million in 2022 and is expected to reach US$ 2,945.14 Million by 2030; it is estimated to record a CAGR of 11.2% from 2022 to 2030

• Life Sciences
• Medical Device

Proton Therapy Systems Market was valued at US$ 1,262.45 Million in 2022 and is expected to reach US$ 2,945.14 Million by 2030; it is estimated to record a CAGR of 11.2% from 2022 to 2030

Market News Insights November 28, 2024

The proton therapy systems market in Asia Pacific is expected to grow at the highest CAGR during...

Read More Read more about Proton Therapy Systems Market was valued at US$ 1,262.45 Million in 2022 and is expected to reach US$ 2,945.14 Million by 2030; it is estimated to record a CAGR of 11.2% from 2022 to 2030

Peripheral Embolization Coils Market was valued at US$ 433.06 Million in 2023 and is expected to reach to US$ 613.96 Million by 2031; it is estimated to record a CAGR of 4.5% from 2023 to 2031

• Life Sciences
• Medical Device

Peripheral Embolization Coils Market was valued at US$ 433.06 Million in 2023 and is expected to reach to US$ 613.96 Million by 2031; it is estimated to record a CAGR of 4.5% from 2023 to 2031

Market News Insights November 25, 2024

Rise in Prevalence of Aortic Aneurysm Drives Peripheral Embolization Coils Market Growth An aortic aneurysm is a...

Read More Read more about Peripheral Embolization Coils Market was valued at US$ 433.06 Million in 2023 and is expected to reach to US$ 613.96 Million by 2031; it is estimated to record a CAGR of 4.5% from 2023 to 2031

Arterial Blood Gas Kits Market was valued at US$ 712.46 Million in 2023 and is expected to reach US$ 1,298.07 Million by 2031; it is estimated to record a CAGR of 7.8% from 2023 to 2031

• Life Sciences
• Medical Device

Arterial Blood Gas Kits Market was valued at US$ 712.46 Million in 2023 and is expected to reach US$ 1,298.07 Million by 2031; it is estimated to record a CAGR of 7.8% from 2023 to 2031

Market News Insights November 22, 2024

The increasing incidence of respiratory diseases and the rising number of admissions to emergency units in hospitals...

Read More Read more about Arterial Blood Gas Kits Market was valued at US$ 712.46 Million in 2023 and is expected to reach US$ 1,298.07 Million by 2031; it is estimated to record a CAGR of 7.8% from 2023 to 2031

Ovarian Cancer Drugs Market was valued at US$ 2.1 Billion in 2022 and is expected to reach tUS$ 3.8 Billion by 2030; it is estimated to record a CAGR of 7.7% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Ovarian Cancer Drugs Market was valued at US$ 2.1 Billion in 2022 and is expected to reach tUS$ 3.8 Billion by 2030; it is estimated to record a CAGR of 7.7% from 2022 to 2030

Market News Insights November 20, 2024

Rising Incidence of Ovarian Cancer Propels Demand for Therapeutic Options Ovarian cancer is the seventh most common...

Read More Read more about Ovarian Cancer Drugs Market was valued at US$ 2.1 Billion in 2022 and is expected to reach tUS$ 3.8 Billion by 2030; it is estimated to record a CAGR of 7.7% from 2022 to 2030

South America Arthroscopy Procedures and Products Market was valued at US$ 445.94 Million in 2023 and is expected to reach US$ 702.46 Million by 2031; it is estimated to record a CAGR of 5.8% from 2023 to 2031

• Life Sciences
• Medical Device

South America Arthroscopy Procedures and Products Market was valued at US$ 445.94 Million in 2023 and is expected to reach US$ 702.46 Million by 2031; it is estimated to record a CAGR of 5.8% from 2023 to 2031

Market News Insights November 8, 2024

Growing Prevalence of Musculoskeletal Disorders Drives South America Arthroscopy Procedures and Products Market Musculoskeletal disorders such as...

Read More Read more about South America Arthroscopy Procedures and Products Market was valued at US$ 445.94 Million in 2023 and is expected to reach US$ 702.46 Million by 2031; it is estimated to record a CAGR of 5.8% from 2023 to 2031

France Stretchers Market was valued at US$ 100.51 Million in 2022 and is expected to reach US$ 155.55 Million by 2030; it is estimated to record a CAGR of 5.6% from 2022 to 2030

• Life Sciences
• Medical Device

France Stretchers Market was valued at US$ 100.51 Million in 2022 and is expected to reach US$ 155.55 Million by 2030; it is estimated to record a CAGR of 5.6% from 2022 to 2030

Market News Insights November 6, 2024

Flourishing Medical Tourism to Offer Opportunities for France Stretchers Market During 2022–2030 According to a report by...

Read More Read more about France Stretchers Market was valued at US$ 100.51 Million in 2022 and is expected to reach US$ 155.55 Million by 2030; it is estimated to record a CAGR of 5.6% from 2022 to 2030

Needle-Free Drug Delivery Devices Market was valued at US$ 14.76 Billion in 2023 and is expected to reach US$ 28.42 Billion by 2031; it is estimated to record a CAGR of 8.5% from 2023 to 2031

• Life Sciences
• Medical Device

Needle-Free Drug Delivery Devices Market was valued at US$ 14.76 Billion in 2023 and is expected to reach US$ 28.42 Billion by 2031; it is estimated to record a CAGR of 8.5% from 2023 to 2031

Market News Insights October 30, 2024

Increasing R&D Expenditures in Pharmaceutical Companies Acts as Opportunity of Needle-Free Drug Delivery Devices Market   Research...

Read More Read more about Needle-Free Drug Delivery Devices Market was valued at US$ 14.76 Billion in 2023 and is expected to reach US$ 28.42 Billion by 2031; it is estimated to record a CAGR of 8.5% from 2023 to 2031

Biologics Market was valued at US$ 469.2 Billion in 2023 and is expected to reach US$ 1,793.9 Billion by 2031; it is estimated to record a CAGR of 18.2% from 2023 to 2031

• Life Sciences
• Pharmaceuticals

Biologics Market was valued at US$ 469.2 Billion in 2023 and is expected to reach US$ 1,793.9 Billion by 2031; it is estimated to record a CAGR of 18.2% from 2023 to 2031

Market News Insights October 29, 2024

Biologics are among the most promising avenues in the pharmaceutical industry, offering a unique approach to treating...

Read More Read more about Biologics Market was valued at US$ 469.2 Billion in 2023 and is expected to reach US$ 1,793.9 Billion by 2031; it is estimated to record a CAGR of 18.2% from 2023 to 2031